Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Avanir's AVP-825 Approval Could be Delayed
Yahoo/Zacks.com
Wednesday, November 12, 2014 - 8:35am
tags:
Avanir, AVP-825, migraines
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir
Yahoo/Zacks.com
Wednesday, November 12, 2014 - 8:33am
tags:
Bristol-Myers Squibb, hepatitis C, daclatasvir
Amgen psoriasis drug tops J&J's Stelara in Phase III study
Yahoo/Reuters
Wednesday, November 12, 2014 - 8:32am
tags:
Amgen, psoriasis, JNJ, brodalumab, Stelara
Major Medical Centers ask Congress to Probe Genentech Distribution Shift
WSJ Pharmalot
Tuesday, November 11, 2014 - 3:41pm
tags:
Genentech, distribution, Ascension
Boston Scientific Shows Strength on Core Market Stabilization
Yahoo/Zacks.com
Tuesday, November 11, 2014 - 3:35pm
tags:
Boston Scientific, devices, earnings
AcelRx Pharmaceuticals (ACRX) Stock Rises After Third-Quarter Earnings Report
TheStreet.com
Tuesday, November 11, 2014 - 3:33pm
tags:
AcelRx, earnings
Takeda recruits GE to help discover new liver treatments
Fierce Biotech
Tuesday, November 11, 2014 - 1:17pm
tags:
Takeda, GE Healthcare, liver disease, diagnostics, R&D
Gilead hepatitis C drug highly effective in cirrhosis patients
Yahoo/Reuters
Tuesday, November 11, 2014 - 1:14pm
tags:
Gilead Sciences, cirrhosis, Harvoni
Why Pfizer Is At A Technical 'Fork In The Road'
Yahoo/Benzinga
Tuesday, November 11, 2014 - 1:13pm
tags:
Pfizer
Is a Surprise Coming for bluebird bio (BLUE) This Earnings Season?
Yahoo/Zacks.com
Tuesday, November 11, 2014 - 11:05am
tags:
Bluebird Bio, earnings
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tuesday, November 11, 2014 - 10:53am
tags:
drug pricing, biotech, AbbVie, AstraZeneca, Bristol-Myers Squibb, Dendreon, Gilead Sciences, GSK, Merck, Novartis, Teva Pharmaceutical, Vertex Pharmaceuticals
Biotech upstart Sage sees early efficacy for rare brain seizure drug
Fierce Biotech
Tuesday, November 11, 2014 - 10:48am
tags:
SAGE Therapeutics, SAGE-547
Pradaxa antidote enters Phase III
Medical Marketing and Media
Tuesday, November 11, 2014 - 10:44am
tags:
Pradaxa, Boehringer Ingelheim
Arena And Vivus Investors Need To Watch Orexigen
Seeking Alpha
Tuesday, November 11, 2014 - 10:38am
tags:
Arena Pharmaceuticals, Orexigen, Vivus, obesity
Does a Positive Result for the Vytorin Trial Really Help Merck?
WSJ Pharmalot
Tuesday, November 11, 2014 - 10:33am
tags:
Merck, Vytorin, Zetia, clinical trial data
Achillion Pharmaceuticals (ACHN): A Potential Acquisition Target For Gilead Sciences (GILD)
Bidness Etc.
Tuesday, November 11, 2014 - 10:32am
tags:
Achillion, M&A, Gilead Sciences, hepatitis C
Medtronic (MDT) Reports Escalating Costs For Its Covidien (COV) Deal
Bidness Etc.
Tuesday, November 11, 2014 - 10:26am
tags:
Medtronic, Covidien, M&A, devices
AbbVie Hepatitis C Drug Cures 97% in Transplant Patients Study
Bloomberg
Tuesday, November 11, 2014 - 9:55am
tags:
AbbVie, hepatitis C, ombitasvir, ritonavir, dasabuvir, ABT-450
Shire CEO hints at an upcoming biotech buyout
Fierce Biotech
Tuesday, November 11, 2014 - 9:52am
tags:
Shire, Pharma CEOs, M&A, Flemming Ornskov
Fujifilm flu drug could get Ebola indication by year end
Seeking Alpha
Tuesday, November 11, 2014 - 9:51am
tags:
Fujifilm, ebola virus, Avigan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.